Kavya -

Contract and budgeting professional with 8 years of experience in Clinical Research Study (CRS) contracting across Phase I–IV trials for major pharmaceutical sponsors. At IQVIA, I manage end-to-end budgeting and contract execution for accounts including Biogen and Takeda — spanning therapeutic areas including Oncology, Rare Disease, Vaccines, Pediatric, Real World Evidence, and Early Clinical Development. My scope covers the full contract lifecycle: change orders, final reconciliations, early terminations, and study cancellations. In 2025, I managed 48 change order contracts end-to-end, completed 4 final reconciliations valued $4M–$92.7M, and drove measurable improvements in execution speed and quality — reducing change order execution time from 60 to 45 days and deliverables inaccuracy from 5% to 3% on the Biogen account. I'm recognized internally as the Subject Matter Expert (SME) for the budgeting process — working across LDP, QIP, time-and-money based frameworks, and client-specific budget tools. Beyond execution, I support senior management with on-demand analytics for account-level negotiations and have mentored new joiners through a structured 6-month onboarding program. My background combines an MBA in Marketing with a B.Tech in Information Technology, complemented by credentials in Scrum (CSM), Lean Six Sigma, and Google Project Management. Open to opportunities in clinical research contracting, procurement, and project management across pharma, biotech, and CRO environments.